Lungebetennelse og COVID-19

Pneumokokksykdom - en utfordring sammen med influensa og Covid-19?

Webinar: Pneumonia in the COVID-19 era

v/Professor James D Chalmers
Asthma and Lung UK Chair of Respiratory Research, University of Dundee

  • What is pneumococcal disease?
  • The epidemiology of pneumococcal disease before and during the covid-period
  • Challenges with flu, covid-19 and pneumococcal disease together
  • Co-infection of flu and pneumonia

Foredraget er på engelsk. Varighet: 28 min

Advances in Pneumococcal Disease Protection

v/Tor Molden, Medical Lead Vaccines, Pfizer Norge

  • Pneumococcal disease in Norway
  • PCV 20 licensing pathway
  • PCV20 is built on the extensive experience with PCV13 in adults
  • PCV20 clinical trials
  • Polysaccharide vs. Conjugate vaccine

Varighet: 20 min

Apexxnar
Pneumokokksykdom Konjugert vaksine Kliniske studier Anbefalinger Sikkerhetsinformasjon Filmer – lær mer om Apexxnar Lungebetennelse og COVID-19
Referanser: 

1. APEXXNAR® SPC, 26.08.2022

PP-PNR-NOR-0065